Company news from the 07/18/06 News Brief

Share this article:
Santarus, a specialty pharmaceutical company focused on products treating gastrointestinal diseases, has launched a new full-service Web site to coincide with the launch of its new capsule formulation Zegerid, an immediate release oral proton pump inhibitor for nighttime acid control. The site, zegerid.com, was designed and developed by Compass Healthcare Communications.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Pfizer seeks wider Xeljanz indication

The company expects to file an sNDA for plaque psoriasis next year.

Recalls dent Stryker Q1 earnings

Sales rose 5% compared to the same period last year.